Overview
The fund generally invests in all equities included in the SMIM® SMI Mid Index. The relative weightings of the companies correspond to their weightings in the index.
The investment objective is to replicate the price performance and returns of the SMIM® SMI Mid Total Return Index (net of fees). The stock exchange price may differ from the net asset value.
The fund is passively managed.
Benefits
Clients benefit from the flexibility of an exchange-traded investment.
Provides access to the performance of the index with a single transaction.
Optimised risk/return profile thanks to a broad diversification across a range of sectors.
The fund offers a high degree of transparency and cost efficiency.
Risks
This UBS Exchange Traded Fund invests in equities and may therefore be subject to high fluctuations in value. This Fund may not be appropriate for investors who plan to withdraw their money before the recommended holding period disclosed in the PRIIPs KID. All investments are subject to market fluctuations. Every fund has specific risks, which can significantly increase under unusual market conditions. Sustainability risks are not considered as part of the Index selection process. Therefore, sustainability risks are not systematically integrated. As a result, the net asset value of the funds assets is directly dependent on the performance of the underlying index. Losses that could be avoided via active management will not be offset.
Features
| Product category |
UBS Exchange Traded Funds UBS ETF (CH) |
| Product domicile |
Switzerland
|
| Portfolio management |
UBS SA国际传谋 Switzerland AG, Zurich
|
| Fund management |
UBS Fund Management (Switzerland) AG
|
| Custodian bank |
UBS Switzerland AG, Zurich
|
| Day of inception |
April 8, 2010
|
| Currency of account |
CHF
|
| Close of financial year |
June 30
|
| SFDR Classification |
Art.6
|
| Issue / redemption |
daily
|
| Next distribution |
September
|
| Maturity |
Open end
|
| TER (flat fee) |
0.25% p.a.
|
| Minimum investment |
n.a.
|
| Reference Index / Benchmark |
SMIM® Total Return
|
| Securities no. |
11176253
|
| ISIN |
CH0111762537
|
| Bloomberg Ticker |
SMMCHA SW
|
| Reuters Id |
SMMCHA.S
|
| Telekurs Id |
SMIMA
|
Performance and Prices
Percentage growth
as of April 23, 2026
Cumulative
| CHF(%) | EUR(%) | USD(%) | |
| YTD | 2.02 | 3.43 | 3.14 |
| 1M | |||
| 3M | |||
| 6M | |||
| 1Y | |||
| 2Y | 16.24 | 17.23 | 32.96 |
| 3Y | |||
| 5Y | 5.00 | 26.41 | 22.86 |
| ø p.a.5Y | 0.98 | 4.80 | 4.20 |
Current data
| Net asset value | 23.04.2026 | CHF 307.16 |
| High - last 12 months | 26.02.2026 | CHF 319.87 |
| Low - last 12 months | 28.04.2025 | CHF 267.24 |
| Last distribution | 09.09.2025 | CHF 5.15 |
| Total product assets in mn | 23.04.2026 | CHF 1,745.96 |
| Constituents | 31.10.2025 | 30.00 |
Structures
By the 10 largest positions (in %, as of March 31, 2026)
|
|
|
| Sandoz Group AG | 10.63 |
| Chocoladefabriken Lindt & Spruengli AG | 9.41 |
| Galderma Group AG | 9.33 |
| Schindler Holding AG | 6.20 |
| Helvetia Baloise Holding AG | 6.18 |
| SGS SA | 5.49 |
| VAT Group AG | 5.09 |
| Julius Baer Group Ltd | 4.69 |
| Swiss Prime Site AG | 4.24 |
| Straumann Holding AG | 3.79 |
Fees
TER (flat fee)
0.25%
Max. redemption commission
3.00%
Max. issuing commission
5.00%
Distribution fee
(see info)
Distributions
From
01-Nov-2020
To
01-Nov-2021
|
Date of distribution
|
Pay date
|
Cps no.
|
Currency
|
Tax domicile CH gross amount
|
Tax domicile CH net amount
|
Tax domicile not CH gross amount
|
Tax domicile not CH net amount
|
Remarks
|
|||||||||||
| 05.09.2025 | 09.09.2025 | 28 | CHF | 4.42 | 2.87 | 4.42 | 2.87 | Income | 05.09.2025 | 09.09.2025 | 29 | CHF | 0.73 | 0.73 | 0.73 | 0.73 | Capital gain or income from direct property |
Sales Authorisations
Literature
Brochures
Agreement / Prospectus
|
Document type
|
Document Language
|
|||
| Prospectus |
|
|
||
| Key Information Document |
|
|
|
|
| Past performance |
|
|
|
|
| Previous performance scenario |
|
|
|
|
Reportings
|
Document type
|
Document Language
|
| Solvency II Reporting Q1 |
|
| Solvency II Reporting Q2 |
|
| Solvency II Reporting Q3 |
|
| Solvency II Reporting Q4 |
|
Annual and semi-annual report (accounting on June 30)
|
Document type
|
Document Language
|
|
| Annual report |
|
|
| Annual report 2024 |
|
|
| Annual report 2023 |
|
|
| Annual report 2022 |
|
|
| Annual report 2021 |
|
|
| Annual report 2020 |
|
|
| Annual report 2018 |
|
|
| Annual report 2017 |
|
|
| Annual report 2016 |
|
|
| Annual report 2015 |
|
|
| Annual report 2014 |
|
|
| Annual report 2013 |
|
|
| Semi-annual report |
|
|
| Semi-annual report 2021 |
|
|
| Semi-annual report 2020 |
|
|
| Semi-annual report 2019 |
|
|
| Semi-annual report 2018 |
|
|
| Semi-annual report 2017 |
|
|
| Semi-annual report 2016 |
|
|
| Semi-annual report 2015 |
|
|
| Semi-annual report 2013 |
|
|
| Semi-annual collateral report 2019 |
|
|
| Semi-annual collateral report 2018 |
|
|
Further documents
|
Document type
|
Document Language
|
| UBS ETF Securities Lending Borrowers |
|
| UBS ETFs Securities Lending Report |
|
General information
|
Document type
|
Document Language
|
|||
| Tax list |
|
|
|
|
Please wait for the requested content to load. If there is no response after several minutes, please reload the page or try again later.